injectable semaglutide 1.75mg Compound Semaglutide
Description
SUMMER SALE UP TO OFF
Low adherence to the prescribed study drugs may have biased our risk estimates towards the null
Nausea is the most common and may start soon after treatment begins, especially at higher doses
Furthermore, pouchees taking GLP-1 drugs took less antibiotics and less anti-diarrhoeal medication
This slightly higher rate may correlate with Mounjaros more potent weight loss outcomes compared to semaglutide
